Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB diagnosis news

Show

From To
A Rapid, Paper-Based Diagnostic Test for Tuberculosis

In a study published in the journal Science and Technology of Advanced Materials (STAM), researchers in Taiwan describe a simple, color-based diagnostic approach with the potential to detect target DNA sequences found in TB-causing mycobacteria -- in just a fraction of the time required for established diagnostic tests.

Published
08 October 2013
From
Science Daily
First-Ever Targeted Roadmap Outlines Steps to End Childhood TB Deaths

The deaths of more than 74 000 children from tuberculosis (TB) could be prevented each year through measures outlined in the first ever action plan developed specifically on TB and children.

Published
02 October 2013
From
WHO
Plan to stop TB in kids overdue but problematic

Health officials are embarking on an ambitious plan to wipe out tuberculosis in children worldwide, even though they don't know exactly how many cases there are.

Published
02 October 2013
From
Yahoo! News
Largest ever roll-out of GeneXpert® rapid TB test machines

UNITAID has invested US$ 25.9 million to purchase over 220 GeneXpert® machines and 1.4 million test cartridges for 21 countries in Africa, Eastern Europe and Asia 1. Co-ordinated by WHO and the Stop TB Partnership, this project – known as TBXpert– is estimated to save an additional 62,000 lives.

Published
10 September 2013
From
UNITAID
Rapid diagnostic tests decrease waiting time for drug-resistant TB patients

Results of a new study suggest that three new diagnostic tests could each be used to successfully diagnose drug resistance in tuberculosis patients in a quarter of the time taken by the current method.

Published
08 September 2013
From
Eurekalert Medicine & Health
Engineers create biodegradable needles that penetrate skin and precisely deliver tuberculosis test

Each year, millions of people in the United States get a tuberculosis skin test to see if they have the infection that still affects one third of the world's population. But the standard diagnostic test is difficult to give, because a hypodermic needle must be inserted at a precise angle and depth in the arm to successfully check for tuberculosis.

Published
28 August 2013
From
News-Medical.net
FDA permits marketing of first U.S. test labeled for simultaneous detection of tuberculosis bacteria and resistance to the antibiotic rifampin

The U.S. Food and Drug Administration today allowed marketing of the Xpert MTB/RIF Assay, the first FDA-reviewed test that can simultaneously detect bacteria that cause tuberculosis (TB) and determine if the bacteria contain genetic markers that makes them resistant to rifampin, an important antibiotic for the treatment of TB.

Published
26 July 2013
From
FDA.gov
Rapid test allows for earlier diagnosis of tuberculosis in children

A new test for diagnosing tuberculosis (TB) in children detects roughly two-thirds of cases identified by the current culture test, but in a fraction of the time, according to the results of a study in South Africa supported by the National Institutes of Health.

Published
26 July 2013
From
Medical Xpress
OraSure founders reunite for new project

Two founders of OraSure Technologies, the Bethlehem maker of the OraQuick HIV test, have reunited on a new venture to make a tuberculosis test. Sam Niedbala's new company, TB Biosciences, announced Thursday it had received $1.5 million in funding.

Published
19 July 2013
From
Allentown Morning Call
UNITAID technical report: Tuberculosis diagnostics technology and market landscape

The report reviews the landscape of TB diagnostics - considering current and expected future technologies, as well as critical market issues, highlighting potential market-based approaches to address shortcomings and improve market function.

Published
11 July 2013
From
UNITAID

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.